Vaxart, Inc. (VXRT)

NASDAQ: VXRT · Real-Time Price · USD

0.3558

-0.0142 (-3.84%)

Aug 1, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Oral Recombinant Protein Vaccines	7.38M	Log In	Log In	Log In	Log In	Upgrade
Oral Recombinant Protein Vaccines Growth	6796.26%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
United States	7.38M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	6796.26%	Log In	Log In	Log In	Log In	Upgrade